INDO US BIOTECH
Quarterly Results Analysis [Jun2025]
INDO US BIOTECH Quarterly Results
| Standalone | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹31 Cr | ₹33 Cr | ₹24 Cr | ₹22 Cr | ₹25 Cr | ₹16 Cr | ₹22 Cr | ₹16 Cr |
| Expenses | ₹25 Cr | ₹29 Cr | ₹18 Cr | ₹17 Cr | ₹21 Cr | ₹15 Cr | ₹18 Cr | ₹13 Cr |
| Operating Income | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Profit Before Tax | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr |
| Profit After Tax | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr |
| EPS | ₹2.34 | ₹1.84 | ₹2.52 | ₹2.17 | ₹1.58 | ₹0.26 | ₹1.84 | ₹0.83 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDO US BIOTECH | -2.5% | -0.5% | -46.4% |
| BOMBAY BURMAH TRADING CORPORATION | -1.4% | -0.9% | -31.9% |
| KAVERI SEED COMPANY | 6.2% | 0.6% | 7.7% |
| VENKYS (INDIA) | -3.1% | -8.9% | -23.1% |
| BOMBAY SUPER HYBRID SEEDS | -1.7% | -5.4% | -28.1% |
| MANGALAM GLOBAL ENTERPRISE | 1.5% | -16.3% | 13.3% |
| HARRISONS MALAYALAM | -2.5% | -8.7% | -34.1% |
| TIERRA AGROTECH | -5.9% | 26.3% | -24.6% |
| NATH BIOGENES (INDIA) | -4.3% | -6.7% | -13.1% |
INDO US BIOTECH Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -7.83 % |
| Y-o-Y | 24.48 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2025 | ₹31 Cr | -7.83 | |
| Mar2025 | ₹33 Cr | 41.68 | |
| Dec2024 | ₹24 Cr | 6.27 | |
| Sep2024 | ₹22 Cr | -10.30 | |
| Jun2024 | ₹25 Cr | 56.78 | |
| Mar2024 | ₹16 Cr | -28.71 | |
| Dec2023 | ₹22 Cr | 39.84 | |
| Sep2023 | ₹16 Cr | - | |
INDO US BIOTECH Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 19.38 % |
| Y-o-Y | 48.23 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2025 | ₹5 Cr | 19.38 | |
| Mar2025 | ₹5 Cr | -17.29 | |
| Dec2024 | ₹6 Cr | 8.18 | |
| Sep2024 | ₹5 Cr | 38.77 | |
| Jun2024 | ₹4 Cr | 280.52 | |
| Mar2024 | ₹1 Cr | -77.12 | |
| Dec2023 | ₹4 Cr | 63.45 | |
| Sep2023 | ₹3 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 29.50 % |
| Y-o-Y | 19.09 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2025 | 17.78% | 29.50 | |
| Mar2025 | 13.73% | -41.60 | |
| Dec2024 | 23.51% | 1.77 | |
| Sep2024 | 23.1% | 54.72 | |
| Jun2024 | 14.93% | 142.76 | |
| Mar2024 | 6.15% | -67.92 | |
| Dec2023 | 19.17% | 16.89 | |
| Sep2023 | 16.4% | - | |
INDO US BIOTECH Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 27.63 % |
| Y-o-Y | 48.41 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2025 | ₹5 Cr | 27.63 | |
| Mar2025 | ₹4 Cr | -27.10 | |
| Dec2024 | ₹5 Cr | 15.94 | |
| Sep2024 | ₹4 Cr | 37.58 | |
| Jun2024 | ₹3 Cr | 504.77 | |
| Mar2024 | ₹1 Cr | -85.78 | |
| Dec2023 | ₹4 Cr | 120.66 | |
| Sep2023 | ₹2 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 38.41 % |
| Y-o-Y | 19.19 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2025 | 15.28 % | 38.41 | |
| Mar2025 | 11.04 % | -48.53 | |
| Dec2024 | 21.45 % | 9.10 | |
| Sep2024 | 19.66 % | 53.35 | |
| Jun2024 | 12.82 % | 286.14 | |
| Mar2024 | 3.32 % | -80.07 | |
| Dec2023 | 16.66 % | 57.77 | |
| Sep2023 | 10.56 % | - | |
INDO US BIOTECH Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 27.17 % |
| Y-o-Y | 48.10 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2025 | ₹2.34 | 27.17 | |
| Mar2025 | ₹1.84 | -26.98 | |
| Dec2024 | ₹2.52 | 16.13 | |
| Sep2024 | ₹2.17 | 37.34 | |
| Jun2024 | ₹1.58 | 507.69 | |
| Mar2024 | ₹0.26 | -85.87 | |
| Dec2023 | ₹1.84 | 121.69 | |
| Sep2023 | ₹0.83 | - | |
You may also like the below Video Courses
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs INDO US BIOTECH LTD vs MANGALAM GLOBAL ENTERPRISE LTD